India Cancer Research
Rising Star in AI Innovation & Affordable CAR-T Therapy
Lower CAR-T Cost
vs. Western countries
AI Detection Accuracy
Breast, lung, cervical cancers
Global Generic Drug Share
Affordable worldwide
First Indigenous CAR-T Therapy (NexCAR19)
India developed its own CAR-T cell therapy at 80% lower cost than Western therapies ($40,000 vs $400,000), making life-saving immunotherapy accessible to millions.
Impact:
Democratizing CAR-T access for middle-income patients globally
AI-Powered Cancer Detection
Indian engineers developed AI algorithms that detect breast, lung, and cervical cancers from medical images with 95%+ accuracy, enabling early diagnosis in rural areas.
Impact:
Bringing expert-level diagnosis to underserved communities
Affordable Generic Cancer Drugs
India produces 80% of the world's generic cancer medications, reducing treatment costs by 90% and saving millions of lives globally.
Impact:
Making cancer treatment affordable worldwide
Telemedicine Cancer Care Network
India built the world's largest telemedicine network connecting rural patients to oncology experts, serving 10+ million consultations annually.
Impact:
Eliminating geographic barriers to cancer care
Precision Medicine for Indian Populations
Researchers identified genetic variants unique to South Asian populations, enabling targeted therapies that work better for Indian patients.
Impact:
Personalized cancer treatment for 1.4 billion people
Oral Cancer Prevention Program
India's massive oral cancer screening program reaches 500 million people, detecting cancer early when it's most curable.
Impact:
Reducing oral cancer deaths by 40% in screened populations
Tata Memorial Centre
Mumbai
Asia's largest comprehensive cancer center. Pioneer in indigenous CAR-T therapy, tobacco-related cancers, and public health oncology. Treats 80,000+ patients annually.
Key Specialties:
All India Institute of Medical Sciences (AIIMS)
New Delhi
India's premier medical institution. Leading research in AI cancer detection, precision medicine, and cancer genomics for Indian populations.
Key Specialties:
Regional Cancer Centre
Thiruvananthapuram, Kerala
Model cancer center for affordable, high-quality care. Pioneered community-based cancer screening programs reaching rural populations.
Key Specialties:
India welcomes international patients to cutting-edge, affordable clinical trials
NexCAR19 CAR-T for Blood Cancers
India's indigenous CAR-T therapy for relapsed/refractory leukemia and lymphoma at $40,000 (vs $400,000+ in US).
AI-Guided Precision Radiotherapy
Using artificial intelligence to optimize radiation dosing for head, neck, and breast cancers with fewer side effects.
HPV Vaccine Population Study
Massive nationwide study on HPV vaccination preventing cervical cancer in Indian girls and young women.
Registry-listed trials for India currently tracked in our database, sourced from public trial registries.
